Serra Energy target ROV closes financings

Executive Summary

• Serra Energy Metals Corp. completed a brokered private placement of 7,253,433 subscription receipts at C$0.35 each, raising gross proceeds of $2,538,701.55.
• The financing is part of an amalgamation with ROV Investment Partners Corp., which will result in a reverse takeover and the creation of a new issuer whose primary business will be Uberdoc Inc.’s digital medical platform.
• In addition, ROV completed a non‑brokered special warrant financing raising $461,540, bringing total proceeds from both financings to approximately $3 million, to be used for business milestones and working capital.

Key Details

• Private Placement: 7,253,433 subscription receipts @ C$0.35 each → Gross proceeds: $2,538,701.55.
• Amalgamation Structure: Three‑cornered amalgamation between Serra Energy Metals Corp., ROV Investment Partners Corp., and 1536702 B.C. Ltd.; results in reverse takeover by ROV shareholders; resulting issuer will own Uberdoc Inc. (U.S. digital medical platform).
• Subscription Receipt Conversion: Receipts held in escrow; automatically convert to one unit of ROV (1 common share + ½ warrant) upon satisfaction of escrow conditions, no additional consideration required.
• Resulting Issuer Warrants: Exercise price C$0.50 per share; exercisable for two years after issuance; no resale restrictions post‑transaction.
• Use of Proceeds: Funds held in escrow until closing; thereafter to fund business milestones of the resulting issuer and general working capital.
• Special Warrant Financing (ROV): 1,318,686 special warrants @ C$0.35 each → Gross proceeds: $461,540.
• Total Capital Raised: Approximately $3 million from both private placement and warrant financing.
• Commission & Broker Warrants: ROV paid $139,909 cash commission; issued 399,740 broker warrants (each exercisable for one common share at C$0.35 for 24 months).
• Closing Conditions: Subject to Canadian Securities Exchange (CSE) approval and other customary conditions; trading of Serra Energy Metals shares remains halted pending CSE review.

Notable Quotes

(No direct quotes were provided in the release.)